Replication Data for "Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model"https://doi.org/10.13130/RD_UNIMI/I4YV97Mazzucchelli, SerenaUNIMI Dataverse2021-01-222023-12-06T14:56:19ZThis datatset contains raw data obtained in HFnDOX+tZ project and published in Andreata et al. Sci.reports 2020Medicine, Health and Life SciencesNanomedicineAndreata, F., Bonizzi, A., Sevieri, M. et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep 10, 11425 (2020)., doi, https://doi.org/10.1038/s41598-020-68205-w2021-01-22Mazzucchelli, Serena2020-02-27Credit must be given to the creator of the dataset. Only noncommercial uses of the data are permitted.